In vitro activities of azithromycin and doxycycline against 15 isolates of Chlamydia pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 8, 1996, Pages 1843-1845

  Gnarpe, Judy ^a   Eriksson, Karin ^a   Gnarpe, Håkan ^a  

^a GÄVLE HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

EID: 0029820229     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.8.1843     Document Type: Article

References (15)

1. Belsheim, J., C. Blomqvist, J. Löfberg, and H. Gnarpe. 1983. Tetracycline influences on leukocyte functions. Acta Oto-Rhino-Laryngol. Belg. 37:635-648.
2. Belsheim, J., H. Gnarpe, and S. Persson. 1979. Tetracyclines and host defense mechanisms: interference with leukocyte chemotaxis. Scand. J. Infect. Dis. 11:141-145.
3. Block, S., J. Hedrick, M. R. Hammarschlag, G. H. Cassell, and J. C. Craft. 1995. Comparative safety and efficacy of clarithromycin and erythromycin ethylsuccinate suspensions in the treatment of children with community acquired infections. Pediatr. Infect. Dis. J. 14:471-477.
4. Falck, G., L. Heyman, J. Gnarpe, and H. Gnarpe. 1995. Chlamydia pneumoniae and chronic pharyngitis. Scand. J. Infect. Dis. 27:179-182.
5. Girard, A. E., D. Girard, A. R. English, T. D. Gootz, C. R. Cimochowski, J. A. Faiella, S. L. Haskell, and J. A. Retsema. 1987. Pharmacokinetic and in vitro studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob. Agents Chemother. 31:1948-1954.
6. Gladue, R. P., G. M. Bright, R. E. Isaacson, and M. F. Newborg. 1989. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob. Agents Chemother. 33:277-282.
7. Grayston, J. T. 1992. Chlamydia pneumoniae, strain TWAR pneumonia. Annu. Rev. Med. 43:317-323.
8. Grayston, J. T. 1992. Infections caused by Chlamydia pneumoniae strain TWAR. Clin. Infect. Dis. 15:757-763.
9. Grayston, J. T., C. C. Kuo, S. P. Wang, and J. Altman. 1986. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N. Engl. J. Med. 315:161-168.
10. Hammerschlag, M. R. 1994. Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae. Antimicrob. Agents Chemother. 38:1873-1878.
11. Hammerschlag, M. R., K. Chirgwin, P. M. Roblin, M. Gelling, W. Dumornay, L. Mandel, P. Smith, and J. Schachter. 1992. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin. Infect. Dis. 14:178-182.
12. Kuo, C. C., A. M. Gown, E. P. Benditt, and J. T. Grayston. 1993. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler. Thromb. 13:1501-1504.
13. Kuo, C.-C., L. A. Jackson, L. A. Campbell, and J. T. Grayston. 1995. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8:451-461.
14. Roblin, P. M., G. Montalban, and M. R. Hammerschlag. 1994. Susceptibilities to clarilhromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia. Antimicrob. Agents Chemother. 38: 1588-1589.
15. Saikku, P., M. Leinonen, L. Tenkanen, E. Linnanmäki, M.-R. Ekman, V. Manninen, M. Mänttäri, M. H. Frick, and J. Huttunen. 1992. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann. Intern. Med. 116:273-278.